| 期 |
标题 |
文件 |
| 卷 14, 编号 1 (2012) |
Sravnitel'nyy analiz effektivnosti,bezopasnosti i stoimosti primeneniyarezhimov pemetreksed/tsisplatin,bevatsizumab/gemtsitabin/tsisplatini gemtsitabin/tsisplatin v terapiineploskokletochnogo nemelkokletochnogoraka legkogo pozdnikh stadiy |
|
|
Baraklou K., Orlando M., Orlov S., Rayan N., Deyvi P., Kanivets Y., Khan B., Brnabik A.
|
| 卷 19, 编号 1 (2017) |
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor |
(Rus)
|
|
Ryazhenov V.
|
| 卷 21, 编号 1 (2019) |
Staging and identification of risk groups in pediatric germ cell ovarian tumors |
(Rus)
|
|
Nechushkina I., Nechushkina V., Boychenko E., Susuleva N., Kazantsev A., Kerimov P., Nechushkin M., Rubansky M.
|
| 卷 17, 编号 2 (2015) |
Stereotactic biopsy of breast lesions under x-ray control |
|
|
Manikhas G., Safronova O., Khudjakova T., Barabanova L., Punanova N.
|
| 卷 17, 编号 2 (2015) |
Dental prevention of complications of chemotherapy hematologic diseases in children |
|
|
Lutskaya I., Andreyeva V., Zinovenko O.
|
| 卷 3, 编号 3 (2001) |
Storozhevye limfouzly: ikh poisk i znachenie pri rake molochnoy zhelezy |
|
|
Vel'sher L., Gabuniya Z., Prazdnikov E., Gvakhariya N., Luchshev A., Ovcharov S., Prilepo Y.
|
| 卷 8, 编号 1 (2006) |
Subpopulyatsii transplantiruemykh stvolovykh krovetvornykh kletok |
|
|
Grivtsova L., Tupitsyn N.
|
| 卷 9, 编号 3 (2007) |
Sutent® (Sutent, SU11248) – novyy mul'titargetnyy ingibitor angiogeneza opukholey |
|
|
Imyanitov E.
|
| 卷 15, 编号 1 (2013) |
Diagram of differential diagnostics of stages of ovarian cancer |
|
|
Antoneeva I., Abakumova T., Gening T., Gening S.
|
| 卷 10, 编号 1 (2008) |
Tayverb/Tyverb (lapatinib) – pervyy dvoynoy anti-ErbB1(EGFR)i anti-ErbB2(HER2)-ingibitor v lechenii mestno-rasprostranennogo i metastaticheskogo raka molochnoy zhelezy zaregistrirovan v Rossiyskoy Federatsii |
|
|
- -.
|
| 卷 3, 编号 3 (2001) |
Taksonomicheskaya struktura vozbuditeley infektsiy v onkologicheskoy klinike |
|
|
Dmitrieva N., Smolyanskaya A., Petukhova I., Sokolova E., Sokolova V., Kulaga E., Bagirova N.
|
| 卷 4, 编号 4 (2002) |
Taksony v optimal'noy khimioterapii raka yaichnikov |
|
|
Urmancheeva A.
|
| 卷 4, 编号 3 (2002) |
Taksoter pri lechenii rasprostranennogo raka yaichnikov |
|
|
Kharitonova T.
|
| 卷 11, 编号 3 (2009) |
Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen' |
|
|
Tryakin A.
|
| 卷 19, 编号 2 (2017) |
The treatment of patients with advanced lung cancer associated with EGFR mutation |
(Rus)
|
|
Bolotina L.
|
| 卷 8, 编号 3 (2006) |
Takticheskie podkhody k lecheniyu regionarnykh metastazov u bol'nykh rakom gortani, gortanoglotki, slizistoy obolochki polosti rta i rotoglotki |
|
|
Aydarbekova A., Lyubaev V., Tkachev S., Alieva S., Brzhezovskiy Z.
|
| 卷 19, 编号 2 (2017) |
Targeted therapy in pediatric malignancies treatment: Pediatric Oncology and Haematology Research Institute experience |
(Rus)
|
|
Valiev T., Levashov A., Batmanova N., Senzhapova E., Turupaev K., Tomchik U., Aleskerova G.
|
| 卷 25, 编号 1 (2023) |
Targeted therapy and hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in pediatric and adolescent patients: a pilot protocol results |
(Rus)
|
|
Tsaplina N., Valiev T., Kirgizov K., Varfolomeeva S.
|
| 卷 23, 编号 4 (2021) |
Targeted therapy of brain metastases in patients with ALK-positive non-small cell lung cancer: A review |
(Rus)
|
|
Sakaeva D., Bulavina I.
|
| 卷 16, 编号 3 (2014) |
Targeted therapy for metastatic renal cell carcinoma |
|
|
Porta C., Tsimafeyev I.
|
| 卷 15, 编号 3 (2013) |
Targetnaya terapiya metastaticheskogo raka zheludka: klinicheskiy opyt uspeshnogo lecheniya patsienta s retsidivom raka zheludka |
|
|
Tlish E.
|
| 卷 9, 编号 3 (2007) |
Targetnaya terapiya raka pochki |
|
|
Alekseev B., Shegay P.
|
| 卷 11, 编号 3 (2009) |
Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov |
|
|
Matveev V.
|
| 卷 12, 编号 1 (2010) |
Targetnye preparaty: ratsional'nyyvybor pervoy linii lekarstvennoyterapii disseminirovannogokolorektal'nogo raka |
|
|
Besova N.
|
| 卷 14, 编号 1 (2012) |
Targetnye preparatyi luchevaya terapiya v lecheniimestnorasprostranennogo raka legkogo |
|
|
Ragulin Y.
|
| 卷 11, 编号 4 (2009) |
Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta |
|
|
Orlov S., Dvorakovskaya I., Mosin I., Stel'makh L., Gorokhov A., Martynenko O., Poltoratskiy A.
|
| 卷 13, 编号 3 (2011) |
Tasigna odobrena v Rossiidlya lecheniya vzroslykh patsientovs vpervye vyyavlennym khronicheskimmieloidnym leykozom (KhML) |
|
|
- -.
|
| 卷 9, 编号 2 (2007) |
Telekonferentsiya po probleme raka molochnoy zhelezy Moskva, 21 fevralya 2007 g |
|
|
- -.
|
| 卷 15, 编号 1 (2013) |
Tendentsii v diagnostike i lechenii zlokachestvennykh gliom (Po materialam Kongressa «Trends in Central Nervous System Malignancies» pri podderzhke EORTC, ESMO, EANO. Praga, 22–23 marta 2013 g.) |
|
|
Absalyamova O.
|
| 卷 12, 编号 2 (2010) |
Terapevticheskie problemypri limfome zony mantii |
|
|
Poddubnaya I.
|
| 卷 23, 编号 1 (2021) |
Second-line systemic therapy for metastatic colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Zaleeva A.
|
| 卷 18, 编号 4 (2016) |
Therapy for patients with non-small cell lung cancer in the Russian Federation: EPICLIN-Lung study |
|
|
Tyulyandin S., Imyanitov E., Moiseyenko V., Ponomarenko D., Gurina L., Koroleva I., Karaseva V.
|
| 卷 22, 编号 2 (2020) |
Therapy of Hodgkin lymphoma in Russia during the COVID-19 pandemic |
(Rus)
|
|
Poddubnaya I., Baryakh E., Vorobyev V., Demina E., Zhukov N., Kaplanov K., Konstantinova T., Motorin D., Ptushkin V., Sarzhevsky V., Tumyan G.
|
| 卷 24, 编号 1 (2022) |
Therapy of lymphoproliferative diseases in the era of COVID-19: challenges and solutions |
(Rus)
|
|
Poddubnaya I.
|
| 卷 20, 编号 1 (2018) |
Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series |
(Rus)
|
|
Orlova R., Zhukova L., Ganshina I., Yukalchuk D., Ponomarenko D., Beliak N., Gordeeva O., Erdniev S., Minasyan A., Dashkova A., Sopiya E., Sholokhova E., Gurochkin A.
|
| 卷 23, 编号 4 (2021) |
The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem
The results of the project with the discussion concerning the possibility of optimization approaches for the therapy |
(Rus)
|
|
Editorial B.
|
| 卷 21, 编号 2 (2019) |
The cost-effectiveness of treatment of relapsed/refractory chronic lymphocytic leukemia with a combination of venetoclax and rituximab |
(Rus)
|
|
Rudakova A., Strugov V.
|
| 卷 25, 编号 1 (2023) |
Therapy of chronic pain in cancer patients: Tafalgin use experience. Case report |
(Rus)
|
|
Ognerubov N.
|
| 卷 13, 编号 2 (2011) |
Terapiya erlotinibom v sochetaniis gemtsitabinom pri rasprostranennomi/ili metastaticheskom rakepodzheludochnoy zhelezy |
|
|
Voznyy E., Popov A., Galkin M., Astrakhankina T., Ovsyannikov A., Polivanov G.
|
| 卷 12, 编号 3 (2010) |
Tekhnicheskie vozmozhnosti primeneniyakleevoy substantsii pri khirurgicheskikhvmeshatel'stvakh na organakh bryushnoypolosti |
|
|
Gorskiy V., Agapov M.
|
| 卷 26, 编号 1 (2024) |
Toxicity and safety of the combination of lenvatinib with pembrolizumab in patients with advanced renal cell cancer: The Russian phase IV observational study |
(Rus)
|
|
Volkova M., Kalpinskiy A., Goncharova O., Menshikov K., Karabina E., Dergunov A., Polshina N., Alexandrova E., Lebedinets A., Panov A., Sultanbaev A., Usynin E., Volkonskiy M., Mikhalyuk V., Zukov R., Anzhiganova Y., Gusniev M., Igumnova E., Kuzmicheva S., Pokataev I., Olshanskaya A., Pervakova N., Parsadanova E., Sannikova T., Bystrov A., Dubovichenko D., Miliausha M., Chubenko V., Shkret K., Gorshenina M., Davlatova M., Kosareva A., Lutoshkina O., Maslova O., Makhnutina M., Mishina A., Murzalina M., Podyacheva O., Kalinin S., Mailyan O., Safarova A., Semenova K., Strokova M., Urashkina E., Shmygina O.
|
| 卷 15, 编号 2 (2013) |
Toxicity of trabectedin-based combinations in the treatment of different malignant tumors |
|
|
Cherkasova M., Khokhlova S., Limareva S., Orel N., Gorbounova V., Poddubnaya I., Lyubimova N.
|
| 卷 2, 编号 4 (2000) |
Tomudeks - novyy effektivnyy protivoopukholevyy preparat |
|
|
Lichinitser M.
|
| 卷 4, 编号 4 (2002) |
Topotekan v kachestve II linii khimioterapii raka yaichnikov |
|
|
Gorbunova V.
|
| 卷 4, 编号 1 (2002) |
Topotekan v lechenii raka legkogo: novye vozmozhnosti terapii |
|
|
Bychkov M.
|
| 卷 12, 编号 3 (2010) |
Trabektedin v lekarstvennom lecheniisarkom myagkikh tkaney |
|
|
Gorbunova V., Aliev M., Fedenko A., Bokhyan B., Istomin I.
|
| 卷 3, 编号 1 (2001) |
Translokatsiya t(8;21)(q22;q22) pri ostrom mieloblastnom leykoze u detey |
|
|
Baturina Y., Popa A., Fleyshman E., Sokova O., Kirichenko O., Konstantinova L., Kulagina O., Mayakova S.
|
| 卷 18, 编号 5 (2016) |
Autologous stem cells transplantation in the first remission of follicular lymphoma as "rescue therapy" in patients with unfavorable prognosis factors. The first prospective study results |
|
|
Nesterova E., Kravchenko S., Baryakh E., Misyurina A., Mangasarova Y., Vorobev V., Chernova N., Gemdzhian E., Savchenko V.
|
| 卷 17, 编号 2 (2015) |
Liver transplantation for hepatocellular carcinoma |
|
|
Khubutiya M., Novruzbekov M., Olisov O., Galankina I., Zimina L.
|
| 卷 24, 编号 2 (2022) |
Transthoracic biopsy under the control of computed tomography as a method of differential diagnosis of nodular neoplasms of the lung in outpatient settings: Retrospective cohort study |
(Rus)
|
|
Perepelevskiy A., Stanojevic U., Lazarenko V., Grebenkin E., Sumina O.
|
| 卷 22, 编号 4 (2020) |
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Alexandrova E.
|
| 卷 23, 编号 4 (2021) |
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary) |
(Rus)
|
|
Zhilyakova V.
|
| 卷 18, 编号 3 (2016) |
Tracheal and bronchial plastic resection in patients with lung cancer |
(Rus)
|
|
Khvastunov R., Usachev A.
|
| 卷 19, 编号 1 (2017) |
Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers |
(Rus)
|
|
Stilidi I., Kotyukova A., Lyadov V.
|
| 卷 14, 编号 2 (2012) |
Tretichnyy pokazatel' Glisona kak faktor prognoza retsidiva raka predstatel'noy zhelezy |
|
|
Ognerubova I., Poddubnaya I., Matveev V., Khvan O.
|
| 卷 24, 编号 2 (2022) |
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review |
(Rus)
|
|
Rykov I., Chubenko V.
|
| 卷 3, 编号 2 (2001) |
Tri rezhima khimioterapii disseminirovannogo kolorektal'nogo raka |
|
|
Narimanov M., Bazin I., Mamedov F., Efimov O., Tryakin A., Zharkov S., Tyulyandin S., Garin A.
|
| 卷 3, 编号 4 (2001) |
Tri rezhima khimioterapii disseminirovannogo kolorektal'nogo raka |
|
|
Narimanov M., Bazin I., Mamedov F., Efimov O., Tryakin A., Zharkov S., Tyulyandin S., Garin A.
|
| 卷 4, 编号 4 (2002) |
Trofoblasticheskaya bolezn': novyy vzglyad na lechenie i monitoring |
|
|
Meshcheryakova L., Kozachenko V.
|
| 卷 16, 编号 2 (2014) |
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board |
|
|
Artamonova E., Gorbunova V., Zhukov N., Manzjuk L., Manihas A., Paltuev P., Semiglazov V., Semiglazova T., Stenina M., Tjuljandin S., Chubenko V.
|
| 卷 18, 编号 5 (2016) |
Difficulties of diagnosing of the Langerhans histiocytosis |
|
|
Shatokhin Y., Snezhko I., Kuzub E., Shatokhina O., Matsionis A., Pavilaytite P., Nagornaya G., Gerasimova O., Burnasheva E., Ryabikina E.
|
| 卷 24, 编号 3 (2022) |
Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma (Russian Translation of Cochrane Plain Language Summary (PLS)) |
(Rus)
|
|
Suvorov V.
|
| 卷 25, 编号 1 (2023) |
Improving outcomes for people with a primary malignant brain tumour and their carers through early palliative interventions |
(Rus)
|
|
Ivanchenko K.
|
| 卷 2, 编号 2 (2000) |
Ul'trazvukovaya diagnostika v onkologii. Novye napravleniya i perspektivy razvitiya |
|
|
Sholokhov V.
|
| 卷 9, 编号 1 (2007) |
Ul'trazvukovye kriterii effektivnosti lecheniya raka yaichnikov |
|
|
Sinitsina M., Chekalova M., Gorbunova V., Kedrova A., Mazyrko M.
|
| 卷 18, 编号 2 (2016) |
Improved technique thyroidectomy with lateral modified radical neck dissection |
(Rus)
|
|
Shabunin A., Dolidze D., Podvyaznikov S., Melnik K., Mumladze R., Vardanyan A., Lebedinskiy I., Grachev P.
|
| 卷 16, 编号 2 (2014) |
Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case |
|
|
Bisovskaya Y., Breder V., Medvedeva B., Gorbunova V.
|
| 卷 21, 编号 2 (2019) |
Successful experience of combined immunochemotherapy at refractory course of primary cutaneous peripheral T-cell lymphoma, unspecified |
(Rus)
|
|
Gorenkova L., Kravchenko S., Belousova I., Babicheva L., Kalashnikova D., Poddubnaya I.
|
| 卷 13, 编号 2 (2011) |
Fazlodeks: novye vozmozhnostiendokrinoterapii raka molochnoy zhelezy |
|
|
Vysotskaya I.
|
| 卷 24, 编号 1 (2022) |
Factors associated with the degree of 99mTc-MIBI accumulation in parathyroid glands neoplasms during planar scintigraphy and SPECT/CT in primary hyperparathyroidism |
(Rus)
|
|
Slashchuk K., Degtyarev M., Rumyantsev P., Rebrova O., Elfimova A., Selivanova L., Mokrysheva N.
|
| 卷 8, 编号 3 (2006) |
Faktory prognoza v opredelenii ob\"ema operatsii pri differentsirovannom rake shchitovidnoy zhelezy |
|
|
Brzhezovskiy V., Lyubaev V., Kochurina G., Subramanian S.
|
| 卷 7, 编号 1 (2005) |
Faktory prognoza pri rake molochnoy zhelezy |
|
|
Bozhok A., Semiglazov V., Semiglazov V., Arzumanov A., Kletsel' A.
|
| 卷 18, 编号 2 (2016) |
Prognostic factors in patients with disseminated gastrointestinal stromal tumors |
(Rus)
|
|
Arkhiri P., Stilidi I., Poddubnaya I., Nered S., Nikulin M., Abu-Khaydar O.
|
| 卷 19, 编号 1 (2017) |
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer |
(Rus)
|
|
Pavlikova O., Kolyadina I., Komov D., Vishnevskaya Y., Poddubnaya I.
|
| 卷 23, 编号 2 (2021) |
Pharmacogenetic markers of chemotherapy toxicity in gastrointestinal tumors: a preliminary analysis |
(Rus)
|
|
Fedorinov D., Geidarov R., Shashkov I., Mikhailovich V., Lyadova M., Pokataev I., Lyadov V.
|
| 卷 19, 编号 1 (2017) |
Pharmacoeconomic characteristics of ixabepilone (Ixempra) monotherapy in patients with locally advanced and metastatic breast cancer resistant to treatment with anthracyclines, taxanes and capecitabin |
(Rus)
|
|
Kolbin A., Mosikyan A., Kurilev A., Balykina Y., Proskurin M.
|
| 卷 15, 编号 4 (2013) |
Pharmacoeconomic potency assignment of targeted agents in the treatment of metastatic colorectal cancer with wild-type Kras |
|
|
Yagudina R., Poddubnaya I., Kulikov A.
|
| 卷 16, 编号 2 (2014) |
Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR) |
|
|
Kolbin A., Kurylev A., Pavlysh A., Proskurin M., Balykina Y.
|
| 卷 19, 编号 1 (2017) |
Pharmacoeconomic aspects of biosimilars |
(Rus)
|
|
Tryakin A., Rudakova A., Fogt S., Vaganov A., Tolkacheva D.
|
| 卷 3, 编号 3 (2001) |
Farmakoekonomicheskiy analiz "stoimost'-poleznost'" kak kriteriy ekonomicheskoy obosnovannosti ispol'zovaniya byudzhetnykh sredstv v onkologii |
|
|
Poddubnaya I., Arkad'eva T., Davidenko I., Rozenbaum L.
|
| 卷 7, 编号 2 (2005) |
Farmorubitsin v klinicheskoy praktike |
|
|
Gorbunova V.
|
| 卷 3, 编号 1 (2001) |
Febril'nye neytropenii u detey s ostrymi mieloidnymi leykozami |
|
|
Ivanova L., Dmitrieva N., Popa A., Bagirova N., Durnov L.
|
| 卷 9, 编号 3 (2007) |
Femara (letrozol) v ad\"yuvantnoy terapii raka molochnoy zhelezy |
|
|
Stenina M.
|
| 卷 10, 编号 2 (2008) |
Femara (letrozol) v sovremennoy terapii raka molochnoy zhelezy |
|
|
Perevodchikova N.
|
| 卷 24, 编号 4 (2022) |
The NETosis phenomena as a functional features of peripheral blood neutrophils and its role in the pathogenesis of infections and oncological diseases: A review |
(Rus)
|
|
Glukhareva A., Afonin G., Melnikova A., Grivtsova L., Kolobaev I., Ivanov S., Kaprin A.
|
| 卷 23, 编号 3 (2021) |
The phenomenon of pseudoprogression in cancer immunotherapy: is everything so unambiguous? |
(Rus)
|
|
Sarzhevskiy V., Melnichenko V., Panshina I., Mochkin N., Bogatyrov V., Borshevetskaya M., Smirnova E., Bannikova A., Samoylova A., Mamedova A., Rukavitsin A., Vasilev S., Bronov O.
|
| 卷 6, 编号 1 (2004) |
Fibrozno - kistoznaya bolezn' |
|
|
Makarenko N., Korzhenkova G.
|
| 卷 23, 编号 3 (2021) |
Physical therapy interventions, other than general physical exercise interventions, in children and adolescents before, during and following treatment for cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Sitnikova V.
|
| 卷 23, 编号 3 (2021) |
Physical activity interventions for disease‐related physical and mental health during and following treatment in people with non‐advanced colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Onischuk A.
|
| 卷 26, 编号 1 (2024) |
Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia |
(Rus)
|
|
Orlova K., Fedyanin M., Simanenkov K., Dergunov A., Goldshmidt P., Saydullaeva A., Bogacheva D., Yavorskaya M., Azanov A., Fedenko A., Bolotina L., Deshkina T., Babina K., Kuzevanova E., Zhukova L., Feoktistova P., Polshina N., Peganova E., Shikina V., Sobolev M., Mironov O., Vaschenko V., Ershova M., Mezhueva A., Orlova S., Tantsyrev D., Taskina D., Teterich A., Karabina E., Kostalanova Y., Bogacheva M., Zhukova N., Orlova R., Zinkevich M., Kazmin A., Volkonskiy M., Voronkova L., Karpova A., Maleyko M., Gorshenina M., Kryuchkova E., Moiseenko F., Murzina Y., Musin S., Ogloblin A., Perminova M., Dumbrava R., Emelyanov S., Protsenko S., Sultanbaev A., Tarasova A., Shakhnovich E., Demchenkova M., Lozovskaya Y., Musaeva K., Pavlova E., Skotnikov R., Chernova V., Chichkanova A., Akhmatova A., Zafirova M., Mischenko A., Ovsienko E., Petrukhnenko V., Syusyukaylova O., Tyugina Y., Shumilkina E., Stroyakovskiy D., Yurchenkov A., Baldin P., Belova A., Diduk O., Konovalova E., Lebedeva L., Li Y., Mashtapa V., Mironenkova Y., Narovenkova K., Pavlikova O., Parsadanova E., Pimonova I., Ruzhnikova A., Sivunova I., Soloveva E., Sosnin M., Temirsultanova K., Tyulegenova M., Khodkevich A., Shakurova N., Efendieva S., Avagimyan K., Anokhina E., Antoshkina M., Borzyanitsa S., Dzhentemirov S., Dmitrochenko M., Zheleznyak A., Komoza Y., Kopanev A., Kornienko T., Krasilnikova M., Lukhmanova D., Mazur N., Markina P., Mitapov Z., Osodoeva S., Prokopenko I., Radyukova I., Ramazanova M., Safarova A., Safronova M., Khabrieva K., Tsygankova N., Chermakova K., Chirkova T., Samoylenko I., Nazarova V., Akhmetyanova A., Demidov L.
|
| 卷 13, 编号 4 (2011) |
Fludarabin v terapii razlichnykhvariantov nekhodzhkinskikh limfom |
|
|
Bessmel'tsev S., Abdulkadyrov K.
|
| 卷 22, 编号 2 (2020) |
Follicular lymphoma |
(Rus)
|
|
Babicheva L., Tumyan G., Osmanov E., Falaleeva N., Kravchenko S., Stefanov D., Poddubnaya I., Myakova N., Rumyantsev A., Maschan A., Ptushkin V., Baikov V., Kovrigina A., Krivolapov I., Konovalov D., Nevolsky A., Ivanov S., Khaylova Z., Gevorkian T.
|
| 卷 24, 编号 4 (2022) |
Fosaprepitant: current options to prevent chemotherapy-induced nausea and vomiting: A review |
(Rus)
|
|
Ognerubov N.
|
| 卷 14, 编号 4 (2012) |
Fotodinamicheskaya terapiya pri kombinirovannom lechenii bol'nykh melanomoy kozhi |
|
|
Mogilevskiy I., Polsachev V., Slovokhodov E., Magomedov M., Karlova M.
|
| 卷 6, 编号 4 (2004) |
Fragmin v onkologii |
|
|
Ptushkin V.
|
| 卷 10, 编号 1 (2008) |
Fraksiparin v profilaktike tromboticheskikh oslozhneniy u onkoginekologicheskikh bol'nykh |
|
|
Somonova O., Madzhuga A., Elizarova A., Zubrikhina G., Kuznetsov V.
|
| 卷 8, 编号 1 (2006) |
Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom |
|
|
Makarov O.
|
| 卷 3, 编号 4 (2001) |
Ftorafur - pervyy peroral'nyy ftorpirimidin v terapii metastaticheskogo kolorektal'nogo raka |
|
|
Manzyuk L., Perevodchikova N., Gorbunova V., Artamonova E., Rotobel'skaya L., Abramova N.
|
| 卷 9, 编号 1 (2007) |
Ftorafur®. Perspektivy primeneniya v sovremennoy klinicheskoy onkologii |
|
|
Gutorov S.
|
| 卷 14, 编号 3 (2012) |
Fulvestrant - endokrinnaya terapiya rasshirennogo spektra deystviya |
|
|
Meshcheryakov A.
|
| 卷 9, 编号 3 (2007) |
Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie |
|
|
Komarova V., Komarova L., Poddubnaya I.
|
| 卷 18, 编号 4 (2016) |
Fulvestrant in endocrine therapy of recurrent and metastatic breast cancer |
|
|
Vladimirova L.
|
| 卷 12, 编号 4 (2010) |
Fulvestrant vne klinicheskikhissledovaniy (opyt otdeleniya khimioterapii) |
|
|
Voznyy, E., Grishunenkova, E., Astrakhankina, T., Popov, A., Galkin M.
|
| 卷 14, 编号 4 (2012) |
Fulvestrant (Fazlodeks)v dozirovke 500 mg uvelichivaet medianuobshchey vyzhivaemosti na 4,1 mes po sravneniyus dozirovkoy 250 mg |
|
|
- -.
|
| 卷 9, 编号 4 (2007) |
Kharakteristika granulotsitarnogo koloniestimuliruyushchego faktora: pokazaniya k primeneniyu |
|
|
Finogenova N.
|
| 卷 25, 编号 1 (2023) |
Characteristics of the receptor phenotype of tumor-associated immune cells of the epithelial-mesenchymal microenvironment of ovarian cancer |
(Rus)
|
|
Zhurman V.
|
| 卷 2, 编号 1 (2000) |
Khimioimmunoterapiya disseminirovannoy melanomy |
|
|
Bulat Y.
|
| 卷 14, 编号 3 (2012) |
Khimioluchevaya terapiya ploskokletochnogo mestnorasprostranennogo anal'nogo raka (klinicheskiy sluchay) |
|
|
Elizbaryan K., Kazantseva M., Davidenko I., Potemin S., Andreev D., Burdik O., Stukan' A.
|
| 卷 12, 编号 2 (2010) |
Khimioterapiya bol'nykhrasprostranennym rakom tolstoy kishki |
|
|
Fedyanin M., Tryakin A., Tyulyandin S.
|
| 卷 4, 编号 1 (2002) |
Khimioterapiya v lechenii zlokachestvennykh vnutrimozgovykh opukholey |
|
|
Kobyakov G.
|
| 卷 26, 编号 1 (2024) |
EDP chemotherapy combined with somatostatin analogues and mitotane in the treatment of disseminated adrenocortical carcinoma: a clinical case |
(Rus)
|
|
Magamedova O., Oganesyan L., Feoktistova P., Feidorov I.
|
| 卷 6, 编号 2 (2004) |
Khimioterapiya nemelkokletochnogo raka legkogo s ispol'zovaniem oksaliplatina(eloksatin) |
|
|
Bychkov M., Bol'shakova S., Bychkov Y.
|
| 卷 6, 编号 2 (2004) |
Khimioterapiya nemelkokletochnogo raka legkogo: vybor pervoy linii |
|
|
Gorbunova V.
|
| 卷 12, 编号 2 (2010) |
Khimioterapiya raka sheyki matki:rol' topotekana v bor'be za uvelichenievyzhivaemosti i uluchshenie kachestvazhizni patsientov |
|
|
Kharitonova T., Poddubnaya I.
|
| 卷 23, 编号 4 (2021) |
Surgical treatment of recurrent ovarian cancer: A review |
(Rus)
|
|
Egenov O., Stilidi I., Tyulyandina A.
|
| 卷 18, 编号 4 (2016) |
Surgical treatment and clinicopathological characteristics of patients with neuroendocrine neoplasms of the stomach |
|
|
Bokhyan V., Peregorodiev I., Delektorskaya V., Arkhiri P., Stilidi I.
|
| 卷 14, 编号 2 (2012) |
Khirurgicheskoe lechenie mestnorasprostranennogo i retsidivnogo orofaringeal'nogo raka v plane kombinirovannogo i kompleksnogo podkhoda |
|
|
Sikorskiy D., Volodin A., Chernyavskiy A., Podvyaznikov S.
|
| 卷 24, 编号 3 (2022) |
The surgical treatment of locally advanced angiosarcoma of the anterior mediastinum. A clinical case |
(Rus)
|
|
Novikov D., Chekini A., Avturkhanov T., Mkrtumyan R.
|
| 卷 22, 编号 4 (2020) |
Surgical treatment for pelvic bone metastases |
(Rus)
|
|
Buharov A., Derzhavin V., Erin D., Yadrina A., Aliev M.
|
| 卷 20, 编号 2 (2018) |
Surgery for early-stage ovarian cancer |
(Rus)
|
|
Nechushkina V., Morkhov K., Abduragimova Z., Kuznetsov V., Selchuk V., Dmitriev V.
|
| 卷 22, 编号 1 (2020) |
Surgical treatment of trophoblastic disease. Modern concept and contradictions (literature review) |
(Rus)
|
|
Maslennikov A., Meshcheriakova L., Kuznetsov V., Kozachenko V., Komarov I.
|
| 卷 15, 编号 2 (2013) |
Surgical stading local – cervical cancer incidence |
|
|
Kargopolova M., Maximov S., Berlev I., Boyarkina M., Meshkova I., Khadzhimba A., Novikov S., Krzhivitsky P., Ponomareva O., Urmancheeva A., Ivanzov A., Guseynov K., Vishinskaya E., Matveeva N.
|
| 卷 14, 编号 4 (2012) |
Khirurgiya raka zheludka u bol'nykh starcheskogo vozrasta: sovremennoe sostoyanie problemy |
|
|
Stilidi I., Nered S., Rokhoev G.
|
| 卷 8, 编号 4 (2006) |
Khronicheskiy B-kletochnyy limfoleykoz: faktory prognoza pri lechenii fludarabinom i khlorambutsilom |
|
|
Nikitin E.
|
| 卷 8, 编号 2 (2006) |
Khronicheskiy virusnyy gepatit S i limfoproliferativnye zabolevaniya |
|
|
Lepkov V., Storozhakov G., Kosyura S., Volynkina V., Oskanova R., Sherstnev V., Kondrat'eva T., Sholokhova E., Probatova N.
|
| 卷 22, 编号 3 (2020) |
Chronic lymphocytic leukemia/small lymphocytic lymphoma |
(Rus)
|
|
Nikitin E., Bialik T., Zaritskii A., Iseber L., Kaplanov K., Lopatkina T., Lugovskaia S., Mukhortova O., Osmanov E., Poddubnaya I., Samoilova O., Stadnik E., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
|
| 卷 14, 编号 4 (2012) |
Tselesoobraznost' prodolzheniya terapii bevatsizumabom posle progressirovaniya u bol'nykh metastaticheskim kolorektal'nym rakom |
|
|
Dobrova N., Gutorov S., Chernoglazova E.
|
| 卷 10, 编号 3 (2008) |
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy |
|
|
Besova N., Khokhlova S., Romanov I., Gorbunova V., Matyakin E.
|
| 卷 10, 编号 4 (2008) |
Tsetuksimab pri lechenii metastaticheskogo kolorektal'nogo raka |
|
|
Sekacheva M., Skipenko O.
|
| 卷 23, 编号 3 (2021) |
Circulating and disseminated tumor cells as a possible prognostic factor for oncological diseases |
(Rus)
|
|
Kaprin A., Zatsarenko S., Ivanov S., Grivtsova L.
|
| 卷 18, 编号 3 (2016) |
Circulating tumor cell: biology, methods of isolation, clinical significance in breast cancer |
(Rus)
|
|
Nenahova Y., Lyadov V., Poddubnaya I.
|
| 卷 8, 编号 1 (2006) |
Tsitologicheskaya diagnostika zlokachestvennykh limfom |
|
|
Kondrat'eva T.
|
| 卷 25, 编号 3 (2023) |
The frequency of regimens associated with high risk of febrile neutropenia and the incidence of dose-limiting neutropenia among patients receiving cytotoxic therapy for malignancies: the FLAME study results |
(Rus)
|
|
Snegovoy A., Kononenko I., Sorokina I., Berezina A., Prosianikova O.
|
| 卷 23, 编号 1 (2021) |
The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia |
(Rus)
|
|
Sokolova T., Aleksakhina S., Yanus G., Sultanbaev A., Menshikov K., Lysenko A., Zukov R., Zyuzyukina A., Murunova Y., Rossokha E., Bakharev S., Basova E., Kasmynina T., Shumskaya I., Bakshun Y., Musaeva K., Khasanova A., Dmitriev V., Bolieva M., Gadzaova C., Petrenko O., Maksimov D., Vladimirov V., Goldberg V., Popova N., Kibisheva M., Khamgokov Z., Vasilyev A., Iyevleva A., Imyanitov E.
|
| 卷 25, 编号 2 (2023) |
Updates in urologic oncology guidelines: renal cell carcinoma. A review |
(Rus)
|
|
Volkova M., Nosov D., Alekseev B.
|
| 卷 25, 编号 1 (2023) |
Updates in urologic oncology guidelines: prostate cancer: A review |
(Rus)
|
|
Volkova M., Alekseev B., Nosov D., Nyushko K.
|
| 卷 25, 编号 2 (2023) |
Updates in urologic oncology guidelines: urothelial carcinoma. A review |
(Rus)
|
|
Volkova M., Alekseev B., Gladkov O.
|
| 卷 14, 编号 4 (2012) |
Everolimus: novye perspektivy terapii gormonopozitivnogo raka molochnoy zhelezy |
|
|
Kolyadina I., Makarenko N., Poddubnaya I.
|
| 卷 14, 编号 1 (2012) |
Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie) |
|
|
Kolyadina I., Poddubnaya I., Frank G., Komov D., Karseladze A., Ermilova V., Vishnevskaya Y., Makarenko N., Teterin K., Banov S., Guzieva Z.
|
| 卷 27, 编号 1 (2025) |
Evolution of anti-HER2 therapy in advanced HER2+ breast cancer or “why is trastuzumab still a key player?”. A review |
(Rus)
|
|
Grechukhina K., Sukhova M., Kolyago E., Filonenko D., Zhukova L.
|
| 卷 20, 编号 3 (2018) |
The evolution of views on the possibilities of drug therapy in overcoming acquired resistance not associated with Т790М mutation to anti-EGFR drugs in non-small cell lung cancer |
(Rus)
|
|
Karabina E., Lubchenko L., Garunov A.
|
| 卷 3, 编号 1 (2001) |
Ekzemestan (aromazin) v sovremennoy endokrinoterapii bol'nykh rakom molochnoy zhelezy |
|
|
Lichinitser M.
|
| 卷 26, 编号 3 (2024) |
Cost-effectiveness of using granulocyte colony-stimulating factor in the treatment of uterine body leiomyosarcomas. A retrospective analysis |
(Rus)
|
|
Saevets V., Kuzmin N., Shamanova A., Mukhin A., Taratonov A.
|
| 卷 4, 编号 4 (2002) |
Ekspressiya molekulyarno-biologicheskikh markerov i ikh prognosticheskaya znachimost' pri sinovial'noy sarkome |
|
|
Keshta R., Stepanova E.
|
| 卷 10, 编号 3 (2008) |
Ekstranodal'nye nekhodzhkinskie limfomy s porazheniem myagkikh tkaney |
|
|
Bykov D., Subortseva I., Ozdoeva T., Tupitsyn N., Tumyan G., Sorokin E., Kondrat'eva T., Kovrigina A., Poddubnaya I., Semenova A., Khakuy R., Osmanov D.
|
| 卷 17, 编号 5 (2015) |
Extranodal non-Hodgkin's lymphomas of the central nervous system, the testis and the pancreas |
|
|
Babicheva L.
|
| 卷 27, 编号 1 (2025) |
Ectopic adrenocortical adenoma in the renal sinus: A clinical case |
(Rus)
|
|
Trushkin R., Ognerubov N., Sokolov S., Dolgov S., Shcheglov N., Sokolov A., Urusova L., Pachuashvili N.
|
| 卷 25, 编号 3 (2023) |
Endobronchial metastasis of melanoma: a clinical case |
(Rus)
|
|
Ognerubov N., Palkina E., Sayapin O., Ognerubova M.
|
| 卷 7, 编号 3 (2005) |
Endoskopicheskaya diagnostika i lazernaya destruktsiya raka gortani |
|
|
Ungiadze G., Poddubnyy B., Belousova N., Kontsevaya A.
|
| 卷 2, 编号 3 (2000) |
Endoskopicheskaya diagnostika ekstranodal'noy limfosarkomy u detey |
|
|
Gubin A., Poddubnyy B., Kuvshinov Y., Nechipay A., Belousova N., Arkhipov V., Kiselev A., Ordukhanyan Z., Peterson I.
|
| 1201 - 1350 的 1398 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |
